Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy
Authors
Keywords
Alzheimer disease, Tau oligomers, Caspase 3, Cleaved-tau, Tau phosphorylation, Tau inclusions
Journal
Molecular Neurodegeneration
Volume 11, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-02-09
DOI
10.1186/s13024-016-0082-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-ageing pill pushed as bona fide drug
- (2015) Erika Check Hayden NATURE
- Appoptosin-Mediated Caspase Cleavage of Tau Contributes to Progressive Supranuclear Palsy Pathogenesis
- (2015) Yingjun Zhao et al. NEURON
- Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer’s disease and tauopathies
- (2014) Mark Yarchoan et al. ACTA NEUROPATHOLOGICA
- Metformin protects against seizures, learning and memory impairments and oxidative damage induced by pentylenetetrazole-induced kindling in mice
- (2014) Ran-ran Zhao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease
- (2014) M. Yarchoan et al. DIABETES
- Use of Antidiabetic Drugs in the U.S., 2003–2012
- (2014) Christian Hampp et al. DIABETES CARE
- Too Little and Too Much: Hypoactivation and Disinhibition of Medial Prefrontal Cortex Cause Attentional Deficits
- (2014) M. Pezze et al. JOURNAL OF NEUROSCIENCE
- Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage
- (2014) Denise Ferrera et al. NEUROBIOLOGY OF AGING
- Early detection of Alzheimer's disease using PiB and FDG PET
- (2014) Ann D. Cohen et al. NEUROBIOLOGY OF DISEASE
- Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide
- (2014) Krzysztof Łabuzek et al. Pharmacological Reports
- Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2
- (2014) W. De Haes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Insulin dysfunction and Tau pathology
- (2014) Noura B. El Khoury et al. Frontiers in Cellular Neuroscience
- mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies
- (2013) Antonella Caccamo et al. AGING CELL
- Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future
- (2013) Yonas E. Geda et al. Alzheimers & Dementia
- Metformin Retards Aging in C. elegans by Altering Microbial Folate and Methionine Metabolism
- (2013) Filipe Cabreiro et al. CELL
- Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin
- (2013) E. M. Moore et al. DIABETES CARE
- Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer's disease pathology
- (2013) Miranda E. Orr et al. NEUROBIOLOGY OF AGING
- Alzheimer disease in the United States (2010-2050) estimated using the 2010 census
- (2013) L. E. Hebert et al. NEUROLOGY
- Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice
- (2013) Sefika Ozcelik et al. PLoS One
- Novel action of metformin in the prevention of haloperidol-induced catalepsy in mice: Potential in the treatment of Parkinson's disease?
- (2013) Halimah A. Adedeji et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Metformin improves healthspan and lifespan in mice
- (2013) Alejandro Martin-Montalvo et al. Nature Communications
- A high-fat-diet-induced cognitive deficit in rats that is not prevented by improving insulin sensitivity with metformin
- (2012) A. D. McNeilly et al. DIABETOLOGIA
- An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers
- (2012) Theresa R. Bomfim et al. JOURNAL OF CLINICAL INVESTIGATION
- Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
- (2012) Konrad Talbot et al. JOURNAL OF CLINICAL INVESTIGATION
- Metformin, Other Antidiabetic Drugs, and Risk of Alzheimer's Disease: A Population-Based Case-Control Study
- (2012) Patrick Imfeld et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats
- (2012) Hiranya Pintana et al. LIFE SCIENCES
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice
- (2012) Jiejie Li et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks
- (2011) Brian Magnuson et al. BIOCHEMICAL JOURNAL
- Metformin slows down aging and extends life span of female SHR mice
- (2011) Vladimir N. Anisimov et al. CELL CYCLE
- Cellular and molecular mechanisms of metformin: an overview
- (2011) Benoit Viollet et al. CLINICAL SCIENCE
- Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models
- (2011) Xiyun Chai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Clk2 and B56β Mediate Insulin-Regulated Assembly of the PP2A Phosphatase Holoenzyme Complex on Akt
- (2011) Joseph T. Rodgers et al. MOLECULAR CELL
- Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer’s-like changes
- (2011) Amit Gupta et al. NEUROPHARMACOLOGY
- Characterization of tau fibrillization in vitro
- (2010) Shaohua Xu et al. Alzheimers & Dementia
- Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau
- (2010) Antonella Caccamo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cell-Mediated Neuroprotection in a Mouse Model of Human Tauopathy
- (2010) D. W. Hampton et al. JOURNAL OF NEUROSCIENCE
- Caspase activation precedes and leads to tangles
- (2010) Alix de Calignon et al. NATURE
- Tsc2-Rheb signaling regulates EphA-mediated axon guidance
- (2010) Duyu Nie et al. NATURE NEUROSCIENCE
- Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling
- (2010) E. Kickstein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Early behavioural markers of disease in P301S tau transgenic mice
- (2009) Maria Luisa Scattoni et al. BEHAVIOURAL BRAIN RESEARCH
- Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: Effects on axonal viability
- (2009) Laura Gasparini et al. NEUROBIOLOGY OF AGING
- Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription
- (2009) Y. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Analysis of Tau Phosphorylation and Truncation in a Mouse Model of Human Tauopathy
- (2007) Patrice Delobel et al. AMERICAN JOURNAL OF PATHOLOGY
- Amyloid beta oligomers induce impairment of neuronal insulin receptors
- (2007) Wei-Qin Zhao et al. FASEB JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started